Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenCC-BIO Vaccine in Infants, Children and Adolescents
NCT02858570Phase 3Unknown
- Sponsor
- Immunobiological Technology Institute
- Start
- Sep 2018
- Primary completion
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcus C conjugate vaccine in meningococcal meningitis, sponsored by Immunobiological Technology Institute. Status: unknown.
02
Drugs
meningococcus C conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT02858570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858570.